UBS Group
REFR icon

UBS Group’s Research Frontiers REFR Stock Holding History

UBS Group’s Portfolio REFR Stock Details REFR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08K Sell
1,174
-1,828
-61% -$2K ﹤0.01% 9631
2025
Q4 		$3.93K Sell
3,002
-4,549
-60% -$7.68K ﹤0.01% 8920
2025
Q3 		$12K Sell
7,551
-12,862
-63% -$19.5K ﹤0.01% 8455
2025
Q2 		$33.5K Buy
20,413
+15,413
+308% +$22.6K ﹤0.01% 8086
2025
Q1 		$5.65K Buy
5,000
+4,194
+520% +$6K ﹤0.01% 8968
2024
Q4 		$1.38K Sell
806
-85,802
-99% -$168K ﹤0.01% 9253
2024
Q3 		$190K Buy
86,608
+1,208
+1% +$2.5K ﹤0.01% 5912
2024
Q2 		$157K Buy
85,400
+77,635
+1,000% +$136K ﹤0.01% 5834
2024
Q1 		$10.1K Buy
+7,765
New +$8.52K ﹤0.01% 7246
2023
Q4 		– Sell
-678
Closed -$732 – 9787
2023
Q3 		$732 Sell
678
-217
-24% -$329 ﹤0.01% 8308
2023
Q2 		$1.43K Sell
895
-38
-4% -$61 ﹤0.01% 7922
2023
Q1 		$1.59K Sell
933
-4,243
-82% -$8.38K ﹤0.01% 8698
2022
Q4 		$9.89K Buy
+5,176
New +$11.8K ﹤0.01% 8596
2022
Q2 		– Sell
-3,628
Closed -$7K – 10823
2022
Q1 		$7K Buy
3,628
+45
+1% +$83 ﹤0.01% 8839
2021
Q4 		$6K Buy
+3,583
New +$7.67K ﹤0.01% 9287
2021
Q3 		– Sell
-9,908
Closed -$23K – 9985
2021
Q2 		$23K Buy
9,908
+4,398
+80% +$11K ﹤0.01% 7192
2021
Q1 		$16K Sell
5,510
-9,028
-62% -$35K ﹤0.01% 7577
2020
Q4 		$41K Buy
14,538
+14,189
+4,066% +$40K ﹤0.01% 6363
2020
Q3 		$1K Sell
349
-8,204
-96% -$23.8K ﹤0.01% 7824
2020
Q2 		$35K Buy
8,553
+4,177
+95% +$15.5K ﹤0.01% 6173
2020
Q1 		$10K Buy
4,376
+1,378
+46% +$4.41K ﹤0.01% 6937
2019
Q4 		$9K Buy
2,998
+45
+2% +$144 ﹤0.01% 7347
2019
Q3 		$9K Buy
2,953
+7
+0.2% +$27 ﹤0.01% 7224
2019
Q2 		$10K Buy
2,946
+67
+2% +$190 ﹤0.01% 7072
2019
Q1 		$6K Sell
2,879
-1,370
-32% -$3.16K ﹤0.01% 7094
2018
Q4 		$6K Sell
4,249
-168
-4% -$244 ﹤0.01% 7485
2018
Q3 		$7K Buy
4,417
+2,711
+159% +$2.87K ﹤0.01% 7343
2018
Q2 		$2K Sell
1,706
-222
-12% -$201 ﹤0.01% 7737
2018
Q1 		$2K Sell
1,928
-11,674
-86% -$11.3K ﹤0.01% 7545
2017
Q4 		$14K Buy
13,602
+7,164
+111% +$7.79K ﹤0.01% 6813
2017
Q3 		$8K Buy
6,438
+3,777
+142% +$4.53K ﹤0.01% 7003
2017
Q2 		$3K Buy
2,661
+543
+26% +$682 ﹤0.01% 7300
2017
Q1 		$3K Buy
2,118
+1,127
+114% +$1.94K ﹤0.01% 7196
2016
Q4 		$2K Sell
991
-27,659
-97% -$57.3K ﹤0.01% 7519
2016
Q3 		$74K Sell
28,650
-4,756
-14% -$14.9K ﹤0.01% 5204
2016
Q2 		$122K Buy
33,406
+1,888
+6% +$7.94K ﹤0.01% 4890
2016
Q1 		$143K Buy
31,518
+788
+3% +$3.53K ﹤0.01% 4721
2015
Q4 		$160K Buy
30,730
+1,803
+6% +$9.05K ﹤0.01% 4851
2015
Q3 		$147K Sell
28,927
-9,609
-25% -$51K ﹤0.01% 4890
2015
Q2 		$206K Sell
38,536
-1,773
-4% -$10.4K ﹤0.01% 4841
2015
Q1 		$246K Sell
40,309
-9,465
-19% -$49.2K ﹤0.01% 4713
2014
Q4 		$255K Buy
+49,774
New +$252K ﹤0.01% 4805

Other funds holding REFR

MOS
MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group's REFR Position: Q1 2026 in Review

UBS Group reduced its Research Frontiers (REFR) stake by 61% in Q1 2026, selling an estimated $2K and leaving 1,174 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #9631.

UBS Group first reported a position in REFR in Q4 2014 and has held it in 42 quarters since. The position peaked at $255K in Q4 2014. 35 funds tracked by Wall St. Rank hold REFR as of Q1 2026.

  • UBS Group held 1,174 shares of Research Frontiers worth $1.08K as of Q1 2026.
  • UBS Group sold 1,828 Research Frontiers shares in Q1 2026, an estimated $2K.
  • Research Frontiers made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #9631 holding.
  • UBS Group first reported a position in Research Frontiers in Q4 2014 and has held it in 42 quarters since.
  • UBS Group's Research Frontiers position peaked at $255K in Q4 2014.
  • 35 funds tracked by Wall St. Rank held Research Frontiers as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.